Manchester, 4 October 2017 – Phagenesis announced today that by completing a key clinical study in Europe it has reached the first milestone in its staged acquisition agreement with Nestlé Health Science (NHSc). Under the terms of the agreement, Nestlé … Continue reading
Barcelona, Spain – 21st September 2017 – Phagenesis announced today the official launch of the Phagenyx® Next Generation catheter, the result of company’s engagement to continuous innovation and product improvement. The participants at 7th ESSD Congress and World Dysphagia Summit, … Continue reading
Manchester, UK – 21st July 2017 – Phagenesis Ltd, an important leader in the treatment of dysphagia, announced today that Phagenyx® Next Generation catheter got CE Mark for neurogenic dysphagia. Dysphagia (the inability to swallow safely) is a condition with … Continue reading
